AAAAAA
Results: 26-50/171
Authors:
Kornacker, M
Schlattner, U
Wallimann, T
Verneris, MR
Negrin, RS
Kornacker, B
Staratschek-Jox, A
Diehl, V
Wolf, J
Citation: M. Kornacker et al., Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis, INT J CANC, 94(4), 2001, pp. 513-519
Authors:
Muschen, M
Re, D
Betz, B
Moers, C
Wolf, J
Niederacher, D
Diehl, V
Beckmann, MW
Citation: M. Muschen et al., Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene, INT J CANC, 92(2), 2001, pp. 309-310
Authors:
Manzke, O
Tesch, H
Borchmann, P
Wolf, J
Lackner, K
Gossmann, A
Diehl, V
Bohlen, H
Citation: O. Manzke et al., Locoregional treatment of low-grade B-cell lymphoma with CD3 x CD19 bispecific antibodies and CD28 costimulation: I. Clinical phase I evaluation, INT J CANC, 91(4), 2001, pp. 508-515
Authors:
Manzke, O
Tesch, H
Lorenzen, J
Diehl, V
Bohlen, H
Citation: O. Manzke et al., Locoregional treatment of low-grade B-cell lymphoma with CD3 x CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses, INT J CANC, 91(4), 2001, pp. 516-522
Authors:
Re, D
Muschen, M
Ahmadi, T
Wickenhauser, C
Staratschek-Jox, A
Holtick, U
Diehl, V
Wolf, J
Citation: D. Re et al., Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells, CANCER RES, 61(5), 2001, pp. 2080-2084
Authors:
Micksche, M
Lynge, E
Diehl, V
Estape, J
Vertio, H
Faivre, J
Papamichail, M
Daly, PA
Veronesi, U
Dicato, M
Kroes, R
Limbert, E
Holm, LE
Vandenbroucke, A
Davies, T
Citation: M. Micksche et al., Recommendations on cancer screening in the European Union, B CANCER, 88(7), 2001, pp. 687-692
Authors:
Re, D
Staratschek-Jox, A
Holtick, U
Diehl, V
Wolf, J
Citation: D. Re et al., Deregulation of immunoglobulin gene transcription in the Hodgkin-Reed Sternberg cell line L1236, BR J HAEM, 115(2), 2001, pp. 326-328
Authors:
Irsch, J
Wolf, J
Tesch, H
Diehl, V
Radbruch, A
Staratschek-Jox, A
Citation: J. Irsch et al., Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines, BR J HAEM, 113(3), 2001, pp. 785-793
Authors:
Kvasnicka, HM
Thiele, J
Schmitt-Graeff, A
Diehl, V
Zankovich, R
Niederle, N
Leder, LD
Schaefer, HE
Citation: Hm. Kvasnicka et al., Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients, BR J HAEM, 112(3), 2001, pp. 727-739
Authors:
Staratschek-Jox, A
Thomas, RK
Zander, T
Massoudi, N
Kornacker, M
Bullerdiek, J
Fonatsch, C
Diehl, V
Wolf, J
Citation: A. Staratschek-jox et al., Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236, BR J CANC, 84(3), 2001, pp. 381-387
Authors:
Kube, D
Holtick, U
Vockerodt, M
Ahmadi, T
Haier, B
Behrmann, I
Heinrich, PC
Diehl, V
Tesch, H
Citation: D. Kube et al., STAT3 is constitutively activated in Hodgkin cell lines, BLOOD, 98(3), 2001, pp. 762-770
Authors:
Weihrauch, MR
Re, D
Scheidhauer, K
Ansen, S
Dietlein, M
Bischoff, S
Bohlen, H
Wolf, J
Schicha, H
Diehl, V
Tesch, H
Citation: Mr. Weihrauch et al., Thoracic positron emission tomography using F-18-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease, BLOOD, 98(10), 2001, pp. 2930-2934
Authors:
Horn, PA
Tesch, H
Staib, P
Schoch, C
Kube, D
Diehl, V
Voliotis, D
Citation: Pa. Horn et al., Significance of AC133 and CD34 expression on acute myeloid leukemia cells, HEMAT BLOOD, 40, 2001, pp. 160-165
Authors:
Staib, P
Schinkothe, T
Wiedenmann, S
Dimski, T
Schoch, C
Voliotis, D
Horn, PA
Tesch, H
Lathan, B
Diehl, V
Citation: P. Staib et al., Prognostic relevance of in-vitro drug sensitivity testing in adult AML, HEMAT BLOOD, 40, 2001, pp. 251-256
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Diehl, V
Niederle, N
Schaefer, HE
Citation: J. Thiele et al., Bone marrow histopathology predicting blast crisis in chronic myeloid leukemia, ACT HAEMAT, 105(4), 2001, pp. 244-246
Authors:
Diehl, V
Schutt, I
Walshe, R
Citation: V. Diehl et al., Published fraud: publication of fraudulent research results, DEUT MED WO, 125(38), 2000, pp. 1112-1114
Authors:
Diehl, V
Josting, A
Citation: V. Diehl et A. Josting, Hodgkin's disease, CANCER J, 6, 2000, pp. S150-S158
Authors:
Scheid, C
Reiser, M
Draube, A
Josting, A
Fuchs, M
Chemnitz, J
Winter, S
Schulz, A
Engert, A
Diehl, V
Sohngen, D
Citation: C. Scheid et al., Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF, J HEMATH ST, 9(4), 2000, pp. 411-413
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Bundschuh, S
Biermann, T
Roessler, G
Wasmus, M
Diehl, V
Zankovich, R
Schaefer, HE
Citation: J. Thiele et al., Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bonemarrow morphologic features in chronic myelogenous leukemia - Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features, AM J CLIN P, 114(1), 2000, pp. 57-65
Authors:
Hubel, K
Mansmann, G
Schafer, H
Oberhauser, F
Diehl, V
Engert, A
Citation: K. Hubel et al., Increase of anti-inflammatory cytokines in patients with esophageal cancerafter perioperative treatment with G-CSF, CYTOKINE, 12(12), 2000, pp. 1797-1800
Authors:
Benedek, D
Kiehl, M
Draube, A
Chemnitz, J
Diehl, V
Sohngen, D
Citation: D. Benedek et al., Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality, LEUK LYMPH, 38(5-6), 2000, pp. 639
Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (Dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue - A highly effective regimen for patients with refractory or relapsed indolent lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 115-123
Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexa-BEAM: An effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 185-187
Authors:
Thiele, J
Kvasnicka, HM
Schmitt-Graeff, A
Zirbes, TK
Birnbaum, F
Kressmann, C
Melguizo-Grahmann, M
Frackenpohl, H
Sprungmann, C
Leder, LD
Diehl, V
Zankovich, R
Schaefer, HE
Niederle, N
Fischer, R
Citation: J. Thiele et al., Bone marrow features and clinical findings in chronic myeloid leukemia - Acomparative, multicenter, immunohistological and morphometric study on 614patients, LEUK LYMPH, 36(3-4), 2000, pp. 295
Authors:
Josting, A
Wolf, J
Diehl, V
Citation: A. Josting et al., Hodgkin disease: prognostic factors and treatment strategies, CURR OPIN O, 12(5), 2000, pp. 403-411